JP2019534286A5 - - Google Patents

Download PDF

Info

Publication number
JP2019534286A5
JP2019534286A5 JP2019522672A JP2019522672A JP2019534286A5 JP 2019534286 A5 JP2019534286 A5 JP 2019534286A5 JP 2019522672 A JP2019522672 A JP 2019522672A JP 2019522672 A JP2019522672 A JP 2019522672A JP 2019534286 A5 JP2019534286 A5 JP 2019534286A5
Authority
JP
Japan
Prior art keywords
patent document
application publication
date
document
bbc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019522672A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019534286A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/058267 external-priority patent/WO2018081254A1/en
Publication of JP2019534286A publication Critical patent/JP2019534286A/ja
Publication of JP2019534286A5 publication Critical patent/JP2019534286A5/ja
Pending legal-status Critical Current

Links

JP2019522672A 2016-10-26 2017-10-25 放射エネルギーによる崩壊の標的とされる癌結合性有色ペプチド Pending JP2019534286A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662412938P 2016-10-26 2016-10-26
US62/412,938 2016-10-26
PCT/US2017/058267 WO2018081254A1 (en) 2016-10-26 2017-10-25 Cancer binding chromatic peptides that are targeted for disintegration by radiant energy

Publications (2)

Publication Number Publication Date
JP2019534286A JP2019534286A (ja) 2019-11-28
JP2019534286A5 true JP2019534286A5 (enExample) 2020-10-08

Family

ID=62025444

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019522672A Pending JP2019534286A (ja) 2016-10-26 2017-10-25 放射エネルギーによる崩壊の標的とされる癌結合性有色ペプチド

Country Status (4)

Country Link
US (1) US20190275173A1 (enExample)
JP (1) JP2019534286A (enExample)
CN (1) CN109963874A (enExample)
WO (1) WO2018081254A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7090958B2 (ja) * 2018-06-01 2022-06-27 アドレイ・ノーティ・バイオファーマ・カンパニー・リミテッド 高活性csf1r阻害薬化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8180436B2 (en) * 2006-04-12 2012-05-15 The Invention Science Fund I, Llc Systems for autofluorescent imaging and target ablation
WO2009045579A2 (en) * 2007-06-14 2009-04-09 The Regents Of The University Of California Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics
US8524239B2 (en) * 2010-07-09 2013-09-03 The United States of America as represented by the Secrectary, Department of Health and Human Services Photosensitizing antibody-fluorophore conjugates
AU2013383382B2 (en) * 2013-03-15 2017-02-23 Purdue Research Foundation Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors

Similar Documents

Publication Publication Date Title
JP2019502892A5 (enExample)
JP2014513356A5 (enExample)
JP2022510882A5 (enExample)
JP2020512939A5 (enExample)
JP2020531120A5 (enExample)
JP2013540292A5 (enExample)
JP2013540293A5 (enExample)
JP2017515162A5 (enExample)
JP2017514639A5 (enExample)
JP2012504317A5 (enExample)
EA201070127A1 (ru) Способы лечения легочной гипертензии, родственных заболеваний и нарушений и композиции для их осуществления
JP2021505241A5 (enExample)
JP2019516789A5 (enExample)
JP2019534156A5 (enExample)
JP2016506890A5 (enExample)
JP2016510582A5 (enExample)
JP2023527970A5 (enExample)
JP2018135352A5 (enExample)
HK1220707A1 (zh) 凝集素样氧化的ldl受体1抗体和使用方法
JP2014508098A5 (enExample)
JP2019527311A5 (enExample)
JP2018505142A5 (enExample)
JP2014532453A5 (enExample)
JP2019534285A5 (enExample)
JP2023503428A5 (enExample)